Tom Keith-Roach
Tom Keith-Roach is the UK president of AstraZeneca, a leading global biopharmaceutical company. He has recently been in the news for announcing AstraZeneca's decision to pause a £200 million investment in Cambridge, attributing the challenging business environment in the UK to pressures from the US, particularly from President Trump.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 5.00 | 0.04% | +0% | 67,886,011 | 29,274 | $2,700,000 | 1,164$ |
| Totals | 1 | 67,886,011 | 29,274 | $2,700,000 | 1,164$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Tom Keith-Roach, the UK president of AstraZeneca, said Britain was 'an increasingly challenging place to bring forward innovation'.
5